Can I read Comparison of Anti-Fracture e Ectiveness of Zoledronate, Ibandronate and Alendronate Versus Denosumab in A Registry-Based Cohort Study on EtoBox?

Comparison of Anti-Fracture e Ectiveness of Zoledronate, Ibandronate and Alendronate Versus Denosumab in A Registry-Based Cohort Study by Amany Hagage is a document available to read on EtoBox.

What is Comparison of Anti-Fracture e Ectiveness of Zoledronate, Ibandronate and Alendronate Versus Denosumab in A Registry-Based Cohort Study about?

This registry-based study of 3068 patients with osteoporosis compared the anti-fracture effectiveness of denosumab versus bisphosphonates. Denosumab was associated with significantly greater risk reduction than alendronate or ibandronate for vertebral and any fractures. No difference in fracture risk reduction was found between zoledronate and denosumab.

Author

Amany Hagage

Language

EN